| cirrhosis |
|
In treating hepatocellular carcinoma (HCC) patients with advanced cirrhosis, one of the most difficult problems is concomitant esophageal varices and hypersplenism.
|
| |
|
The surgical treatment methods for cirrhosis patients complicated with portal hypertension are complicated.
|
| |
|
From 1979 to 2005, 274 cirrhosis patients with portal hypertension who underwent the new treatment strategy were followed up to observe different clinical indexes, which were then compared with those of the traditional surgery treatment.
|
| |
|
Postoperative hepatic insulin-like growth factor-1 (IGF-1) production may be severely disturbed in patients with liver cirrhosis.
|
| |
|
Twenty-four patients with HCC with cirrhosis who underwent hepatectomy were randomly divided into two groups: a PN group (n = 12) and an rhGH + PN group (n = 12).
|
| |
|
These data indicate that rhGH + PN could ameliorate the changes in the GH/IGF-1 axis after hepatectomy for HCC in the setting of cirrhosis.
|
| |
|
Effects of Fuzheng Huayu Decoction on plasma proteome in cirrhosis: preliminary experimental study with rats
|
| |
|
Some proteins related to oxidative stress, cell proliferation and transformation have changed in the plasma of cirrhosis induced by CCl4.
|
| |
|
The search for biochemical predictors of the NAT2 phenotype to optimize prophylaxis and pharmacotherapy of hepatic cirrhosis
|
| |
|
Genetic Predisposition to Alcoholic Toxic Cirrhosis
|
| |
|
Comprehensive analysis of the contribution of genetic factors into predisposition to alcoholic toxic cirrhosis (TC) was performed.
|
| |
|
Liver biopsy revealed hidrophic degeneration in hepatocytes, steatosis, enlargement and inflammation in portal areas and portal central fibrosis, consistent with cirrhosis.
|
| |
|
A genetic predisposition has been suggested in primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC).
|
| |
|
In addition, liver cancer is often followed by a procession of chronic hepatitis or cirrhosis, so that hepatic function is damaged obviously on these bases, which may significantly influence lipid and lipoprotein metabolism in vivo.
|
| |
|
Deaths from suicide, cirrhosis of the liver, delirium tremens and disorders of the nervous system are, with some differences according to diagnostic sub-group, significantly more frequent than in the general population.
|
| |
|
Patients with advanced liver cirrhosis frequently develop the hepatorenal syndrome, a condition characterized by renal failure, marked reduction in renal blood flow and overactivity of endogenous vasoactive systems.
|
| |
|
The development of hepatorenal syndrome (HRS) in decompensated, advanced cirrhosis represents a multifactorial process of functional character with the absence of histological alterations in kidney structure.
|
| |
|
Second, for differential diagnosis of renal failure in liver cirrhosis, an algorithm was developed and the criteria defining the presence of a HRS are given.
|
| |
|
The vasopressing agent terlipressin is a commonly used drug with various indications especially in patients with advanced cirrhosis.
|
| |
|
Due to complex pathophysiologic patterns, different complications of cirrhosis can be specifically treated.
|
| |